Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Smith+Nephew acquisition of Engage Surgical
We are advising Smith+Nephew on the transaction
Legend Biotech $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
Blue Safari Group merger with Bitdeer Technologies
We are advising Blue Safari on the transaction
Iris Energy $215.3 million IPO
The shares are listed on the Nasdaq Global Select Market
Marathon Digital Holdings $650 million convertible senior notes offering
We advised Marathon Digital Holdings on its offering of 1% convertible notes due 2026
IVERIC bio $173.4 million stock offering
We advised the underwriters on the SEC-registered equity offering
P10 $240 million IPO
We advised the underwriters on the IPO and NYSE listing
Regions Bank acquires Sabal Capital Partners
We are advising Regions on the transaction